The Institute of Human Virology, Nigeria (IHVN) was established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine, Baltimore in the United States of America. It has grown to become a leading local non-governmental organization addressing the HIV/AIDS crises in Nigeria through the development of infrastructure for treatment, care, prevention, and support for people living with and those affected by HIV/AIDS but has now expanded its services to other infectious and non-infectious diseases including, cancer, tuberculosis, malaria and other diseases. IHVN is structured to develop and maintain linkages with local and international organizations in collaborative ways that support the Government of Nigeria's health sector strategic plans. IHVN key technical and funding partners are the Centers for Disease Control and Prevention (CDC) and the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Institute, which as of March 2006 was supporting seven treatment sites in five states in Nigeria including the Federal Capital Territory, now offers ARV services in 290 facilities, PMTCT services in 623 facilities, tuberculosis services in 170 facilities and HIV Counseling and Testing Services in 612 facilities under its ACTIONPlusUp project. Also, through funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria, MDR-TB, 13 treatment centers offer treatment for multi-drug resistant tuberculosis and 1830 facilities, malaria services. All these facilities and treatment centers comprise of primary, secondary and tertiary health centers in twenty two states. Eleven of the hospitals it supports are University Teaching Hospitals. IHVN, which has expanded activities to meet the growing public health challenges in Nigeria, has grown into an organization of about 398 staff members, from initial staff strength of ten.